CliffBio
small molecule

QUINIDINE GLUCONATE

QUINIDINE GLUCONATE

Loss of exclusivity—loss of exclusivity
CompanyCycle Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand nameQUINIDINE GLUCONATE
Active ingredientQUINIDINE GLUCONATE
Strength324MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalJanuary 1984
Marketing statusDISCN

More from Cycle Pharmaceuticals

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

QUINIDINE GLUCONATE patent cliff — loss of exclusivity — | CliffBio